A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)

Name: A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)
License: Public Domain

CRISPR Therapeutics AG

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

renal cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 287526
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.